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meta-analyses of passive smoking and coronary heart dis-
ease have been addressed elsewhere in the literature. Spe-
cifically, results in male and female patients are sufficiently
homogeneous to allow their combination.3,4 The various
studies can be, and were, given meaningful quality scores.3,4
The questions of misclassification of smoking status and
exposure status have been adequately dealt with, as has
publication bias.3 Adjustment has been made for potential
confounders,2-4 and positive trends with dose were found
for 16 of 22 studies without the inclusion of the nonex-
posed group.4
Bailar is also worried that the pooled relative risk of
coronary heart disease associated with passive smoking is
large as compared with the risk associated with active smok-
ing. The ratio of excess risks, active to passive, is about
(1.93¡1)÷(1.24¡1), or 3.9, when the risk for active
smokers is measured against that for nonexposed persons
who have never smoked. This is not unusual for an ana-
tomical site that is not in direct contact with tobacco
smoke and for which the dose–response curve is convex
upward.5 For comparison, the best study we have on
breast cancer and active and passive smoking6 found an ac-
tive-to-passive ratio of excess risks of only (3.0¡1)÷
(2.3¡1), or 1.5. Although the data are fewer, similar low
ratios appear to hold for other noncontact cancer sites,
such as the cervix, liver, and brain, and for lymphoma and
leukemia. Probably these ratios are low because so many
of the entities in environmental tobacco smoke that cause
coronary heart disease and cancer are in the vapor phase7;
they therefore are deposited more completely in the lung
and are harder to clear than particle deposits. The toxins
must be cleared into the body fluids, where they can cir-
culate to distant sites, such as the heart or breast.
Bailar appears to prefer a “thoughtful review of the usu-
al type.”1 If so, he should read the review by Kritz et al.,8
which covers the same ground as the study by He et al.2
and others,3,4 but without the meta-analysis. Of course,
Kritz et al. also conclude that environmental tobacco
smoke causes coronary heart disease.
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To the Editor: Many readers would dispute Bailar’s con-
clusion that “we still do not know . . . whether exposure
to environmental tobacco smoke increases the risk of cor-
onary artery disease.” The evidence available to mid-1997
on this topic was reviewed by Australia’s National Health
and Medical Research Council (NHMRC).1 The NHMRC
considered 22 analyses from 16 studies; 17 of the 22
analyses indicated some increase in the risk of coronary
events among nonsmokers with exposure to environmen-
tal tobacco smoke, and in 8 of them the results were sta-
tistically significant. Rather than undertake a quantitative
meta-analysis, the NHMRC summarized the data in terms
of a median relative risk and corresponding interquartile
range. The median estimate of 1.24 (interquartile range,
1.02 to 1.62) is entirely consistent with the pooled esti-
mate of 1.25 (95 percent confidence interval, 1.17 to 1.32)
derived by He et al. and was supported by findings of ex-
cess risks of mortality from all causes in seven of eight pro-
spective studies of passive smoking.
The report from the NHMRC also examined the rela-
tion between passive smoking and coronary heart disease
in light of the criteria proposed by Hill2 and concluded
that “all the evidence put together is reasonably coher-
ent.”1 Like Bailar, the NHMRC drew attention to the rel-
atively large excess risk of coronary heart disease associated
with passive smoking as compared with the risk attendant
on active smoking, but it cited evidence that platelet func-
tion in nonsmokers is particularly sensitive to exposure to
environmental tobacco smoke.3
Whatever the limitations of meta-analysis, the abundant
evidence that passive smoking causes harm to health can
no longer be ignored.
KONRAD JAMROZIK, M.B., B.S., D.PHIL.
GRAHAM A. COLDITZ, M.D., DR.P.H.
Harvard Medical School
Boston, MA 02115
1. NHMRC Working Party. The health effects of passive smoking: a sci-
entific information paper. Canberra, Australia: NHMRC, 1997.
2. Hill AB. The environment and disease: association or causation? Proc 
R Soc Med 1965;58:295-300.
3. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects en-
dothelium and platelets. Arch Intern Med 1989;149:386-9.
To the Editor: In his editorial, Bailar uses several flawed
arguments. His concern about reporting bias might be ap-
propriately applied to the case–control studies, but not to
the cohort studies (10 of the 18 studies analyzed). More-
over, when the two types of studies were analyzed sepa-
rately by He et al., the conclusions were strikingly similar.
The possibility of publication bias was also raised. This is
often a valid criticism of meta-analyses, but it appears mis-
directed in this instance. Specifically, of the 18 studies re-
viewed, 7 found a significant association and 11 did not.
If anything, the bias here is likely to be very small. In ad-
dition, random reporting errors, also mentioned by Bailar,
are likely to attenuate and not spuriously strengthen these
associations.
Bailar considers the range of relative risk of about 1.0 to
2.2 in He et al.’s study to be “very small.” He believes that
uniformity in results is “not necessarily good.” Such com-
ments are only his opinion, and not facts. Finally, Bailar
criticizes the use of a “multiplicative model,” but meta-
analysis must use the models of the original studies and
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